Related Experiment Video
Updated: Apr 25, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Cerebrovascular fibromuscular dysplasia
Marion Boulanger1, Ahmad Nehme2, Emmanuel Touzé3,4
1Service de Neurologie, CHU Caen Normandie, Avenue de la Cote de Nacre, 14000 Caen, France.
Background:
Cerebrovascular fibromuscular dysplasia (FMD), that is, involving the cervical or intracranial arteries, is frequently overlooked despite its association with several neurological manifestations.
Objectives:
To describe cerebrovascular FMD.
Design:
Systematic review.
Data Sources And Methods:
We searched PubMed, Embase, and Medline up to December 2024. We identified additional studies by handsearching the bibliographies of relevant studies. We included articles describing at least one aspect of epidemiology, manifestations, prognosis, and management of cerebrovascular FMD and preferentially focused on studies including ⩾15 patients. The quality of evidence was rated according to the Oxford Centre for Evidence-Based Medicine levels of evidence.
Results:
We included 119 studies. Cerebrovascular FMD predominantly affects women around 50 years of age and most frequently involves the cervical arteries. Cerebrovascular FMD is frequently asymptomatic and incidentally diagnosed. The most common presenting symptoms are headache (8%-52%) and pulsatile tinnitus (17%-23%). Patients with FMD have a higher prevalence of cervical artery dissection (7%-17%) and intracranial saccular aneurysm (7%) compared to the general population. The main complications of cerebrovascular FMD are ischemic stroke (7%-10%), transient ischemic attack (5%-12%), subarachnoid hemorrhage (2%-3%), and intracerebral hemorrhage (0.01%). Webs are the predominant form of FMD in Black populations. Consensus-based recommendations have been summarized in the first international consensus statement on the diagnosis and management of FMD. Imaging of all arteries from brain-to-pelvis is recommended to detect asymptomatic lesions. Antiplatelet therapy is reasonable for patients with cerebrovascular FMD to prevent thromboembolic complications. Endovascular treatment can be considered in patients with risk factors for rupture of an unruptured intracranial aneurysm and in those with recurrent ischemic events despite medical management.
Conclusion:
Existing cross-sectional studies have improved the understanding of the manifestations of cerebrovascular FMD. However, knowledge gaps remain regarding the genetics, pathophysiology, management, and prognosis of cerebrovascular FMD, which should be addressed in future research.
Insights
Cerebrovascular fibromuscular dysplasia (FMD) often affects women and can be asymptomatic or present with headaches. Early diagnosis and management, including imaging and antiplatelet therapy, are crucial for preventing complications like stroke.
Area of Science:
- Vascular Neurology
- Radiology
- Genetics
Background:
- Cerebrovascular fibromuscular dysplasia (FMD) involves arteries in the brain and neck and is often overlooked.
- It is associated with various neurological symptoms, highlighting the need for increased awareness.
Purpose of the Study:
- To provide a comprehensive description of cerebrovascular FMD.
- To synthesize current knowledge on its epidemiology, clinical manifestations, prognosis, and management.
Main Methods:
- A systematic review of studies published up to December 2024, sourced from PubMed, Embase, and Medline.
- Inclusion criteria focused on articles detailing FMD epidemiology, manifestations, prognosis, or management, with a preference for studies involving at least 15 patients.
Main Results:
- The review analyzed 119 studies, revealing FMD predominantly affects women around age 50, often involving cervical arteries.
- Common symptoms include headache and pulsatile tinnitus; complications include stroke and hemorrhage. Webs are prevalent in Black populations.
- Consensus recommendations emphasize brain-to-pelvis imaging and antiplatelet therapy; endovascular treatment is considered for specific cases.
Conclusions:
- Current research has improved understanding of cerebrovascular FMD manifestations.
- Further research is needed to address knowledge gaps in genetics, pathophysiology, management, and long-term prognosis.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Dementia l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Vascular Spasm

